GlaxoSmithKline, PLC and MedTrust Online, LLC have announced the development of CancerTrials App, the first free geolocating cancer clinical trials application for the Apple iPhone and iPad platforms.
With CancerTrials App, cancer doctors can easily find and share information about experimental therapies in clinical trials with their patients. CancerTrials App provides a quick search menu based on 12 common cancers and more advanced features that refine searches based on criteria such as gender, age, trial status and more. Once relevant trials are found, results can be mapped relative to the location of the iPhone or iPad running the application.
“GSK Oncology has always been interested in providing doctors and their patients with the access to the right information about the best therapies that improve patient outcomes,” stated Jeffrey Bloss, M.D., Vice President, Medicine Development Leader for GSK Oncology. “We are pleased to work with MedTrust Online to bring simple yet highly effective information-based solutions to the cancer community.”
“Our community of oncologists continues to ask for information about the latest therapies in a format that fits their busy schedule,” said Dr. Leo Otake, M.D., Ph.D., Vice President of Medical Informatics for MedTrust Online. “This joint development with GSK Oncology has resulted in yet another effective electronic tool that empowers our users and brings cancer doctors closer to their patients.”
CancerTrials App is the first release of a mobile application for several platforms that connects to MedTrust Online’s proprietary databases of oncology information at www.oncocentric.com. Solutions for RIM’s BlackBerry and Google’s Android operating systems will be released over the next several months. Oncologists using mobile communication devices will be able to share more with their patients as they search for the best therapies available in their communities.
